Novel Biologics Data, Technology Stack, and Enterprise Applications
Collaboration
Vendor
Old Product
New Product
Category
Market
VAR/SI
When
Live
Microsoft Legacy Microsoft 365 Collaboration Collaboration n/a 2024 2024
Collaboration Collaboration 2025 2025
IaaS
Vendor
Old Product
New Product
Category
Market
VAR/SI
When
Live
Cloudflare Legacy Cloudflare CDN Content Delivery Network IaaS n/a 2024 2024
eCommerce
Vendor
Old Product
New Product
Category
Market
VAR/SI
When
Live
Automattic Legacy WooCommerce eCommerce eCommerce n/a 2024 2024
AI Development
Vendor
Old Product
New Product
Category
Market
VAR/SI
When
Live
Generative AI Platforms AI Development 2025 2025
CRM
Vendor
Old Product
New Product
Category
Market
VAR/SI
When
Live
Tag Management CRM 2024 2024
IT Decision Makers and Key Stakeholders at Novel Biologics
First Name Last Name Title Function Department Email Phone
No data found
Apps Being Evaluated by Novel Biologics Executives
Date Company Status Vendor Product Category Market
No data found
FAQ - APPS RUN THE WORLD Novel Biologics Technographics

Novel Biologics is a Life Sciences organization based in United States, with around 10 employees and annual revenues of $1.0 million.

Novel Biologics operates a diverse technology stack with applications such as Microsoft 365, Cloudflare CDN and WooCommerce, covering areas like Collaboration, Content Delivery Network and eCommerce.

Novel Biologics has invested in cloud applications and AI-driven platforms to optimize efficiency and growth, collaborating with vendors such as Microsoft, Cloudflare and Automattic.

Novel Biologics recently adopted applications including Slack Connect in 2025, Perplexity in 2025 and Microsoft 365 in 2024, highlighting its ongoing modernization strategy.

APPS RUN THE WORLD maintains an up-to-date database of Novel Biologics’s key decision makers and IT executives, available to Premium subscribers.

Our research team continuously updates Novel Biologics’s profile with verified software purchases, vendor relationships, and digital initiatives identified from public and proprietary sources.

Subscribe to APPS RUN THE WORLD to access the complete Novel Biologics technographics profile, including detailed breakdowns by category, vendor, and IT decision makers.